Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Merck Halts Two Indian Firms From Launching Januvia Copies As It Awaits Crucial Patent Decision

This article was originally published in PharmAsia News

Executive Summary

After halting Aprica in June, Merck has stopped two more Indian companies from a potential launch of sitagliptin copies. But a number of Indian companies are said to be keenly waiting to launch their copies of sitagliptin and a final decision on a patent fight with Glenmark could be the only hurdle holding them back.



Related Companies




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts